CORMORANT ASSET MANAGEMENT, LP – Olema Pharmaceuticals, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$5.74M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
-32.19%
quarter
Olema Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -2.72M | $2.76 | 2.08M | |
| Q2 2022 | share | 0.00% | 0 shares | -395K | $4.07 | 2.08M | |
| Q1 2022 | share | Decrease | -4.05% | -87.87K shares | -11.44M | $4.26 | 2.08M |
| Q4 2021 | share | Decrease | -29.40% | -903.61K shares | -64.39M | $9.4 | 2.16M |
| Q3 2021 | share | 0.00% | 0 shares | -1.29M | $27.56 | 3.07M | |
| Q2 2021 | share | Decrease | -3.82% | -122.05K shares | -19.08M | $27.98 | 3.07M |
| Q1 2021 | share | 0.00% | 0 shares | -43.08M | $33.18 | 3.19M | |
| Q4 2020 | share | Increase | 0.00% | 3.19M shares | 148.16M | $48.08 | 3.19M |